Skip to content

Clinical trials

Phase 3 Glioma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 3 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20041
20051
20061
20071
20082
20092
20101
20161
20172
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting3
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
INSYS Therapeutics Inc2
Radiation Therapy Oncology Group2
Wake Forest University Health Sciences2
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1
DelMar Pharmaceuticals, Inc.1
Eastern Cooperative Oncology Group1
Institut de Recherches Internationales Servier1
Isarna Therapeutics GmbH1
Jazz Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma20
Brain Neoplasms13
Astrocytoma11
Glioblastoma11
Oligodendroglioma7
Central Nervous System Neoplasms6
Gliosarcoma4
Neoplasms4
Ependymoma3
Glioma, Subependymal3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.